Literature DB >> 21185877

Processing of chromogranins/secretogranin in patients with diabetic retinopathy.

Isabelle Fournier1, David Gaucher, Jean-F Chich, Charlotte Bach, Peiman Shooshtarizadeh, Serge Picaud, Tristan Bourcier, Claude Speeg-Schatz, Jean M Strub, Alain Van Dorsselaer, Angelo Corti, Dominique Aunis, Marie-H Metz-Boutigue.   

Abstract

AIMS: Inflammation has been linked to the development of diabetic retinopathy (DR). Chromogranins A, B (CgA, CgB) and secretogranin II (SgII), are prohormones overexpressed in inflammatory diseases. The present study was conducted to evaluate the presence and processing of these prohormones in the vitreous of patients with DR (DV), compared with nondiabetic vitreous (NDV).
METHODS: Thirteen DV and 14 NDV samples were collected during vitreoretinal surgery. ELISA, Western blot, RP-HPLC, dot blot, protein sequencing and mass spectrometry were used to study the quantitative expression and the processing of CgA, CgB and SgII.
RESULTS: CgA, CgB and SgII presence was higher in DV than in NDV. Mean concentration of CgA evaluated by ELISA was 90.8 (± 90.1) n L⁻¹ in DV vs. 29.7 (±20.9) in NDV (p=0.039). In NDV, Western blot indicated that only short CgB-derived peptides were identified. In DV, proteomic analyses showed that long CgA-, CgB- and SgII-derived fragments and α1-antitrypsin were overexpressed, suggesting possible inhibition of the proteolytic process.
CONCLUSIONS: This study shows differences in the presence and endogenous processing of CgA, CgB and SgII from DV vs. NDV. In DV, the increase of complete granins and the attenuation of their endogenous proteolytic processing could participate in DR progression by reducing the presence of regulatory peptides, important for the pro-/anti-angiogenic balance in the eye.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185877     DOI: 10.1016/j.regpep.2010.12.004

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  6 in total

Review 1.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

2.  Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo.

Authors:  Fabienne Soulet; Witold W Kilarski; Florence Roux-Dalvai; John M J Herbert; Izabela Sacewicz; Emmanuelle Mouton-Barbosa; Roy Bicknell; Patricia Lalor; Bernard Monsarrat; Andreas Bikfalvi
Journal:  Mol Cell Proteomics       Date:  2013-05-14       Impact factor: 5.911

Review 3.  Chromogranins: from discovery to current times.

Authors:  Karen B Helle; Marie-Helene Metz-Boutigue; Maria Carmela Cerra; Tommaso Angelone
Journal:  Pflugers Arch       Date:  2017-09-05       Impact factor: 3.657

Review 4.  Chromogranin A: a paradoxical player in angiogenesis and vascular biology.

Authors:  Karen B Helle; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

Review 5.  The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease.

Authors:  Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

Review 6.  Role and function of granin proteins in diabetes mellitus.

Authors:  Zoltan Herold; Marton Doleschall; Aniko Somogyi
Journal:  World J Diabetes       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.